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IL-18 translational inhibition restricts IFN- expression in cres- Interleukin-18 (IL-18), originally designated interferon
centic glomerulonephritis. gamma (IFN-)–inducing factor (IGIF), is a cytokine
Background. Interleukin-18 (IL-18), a potent inducer of in- that has pleiotropic effects on several types of cells, espe-terferon gamma (IFN-) production, is a cytokine involved in
cially immune cells [1]. IL-18 strongly induces IFN-the cell-mediated immune response that is expressed during
inflammatory and pathologic conditions. IFN- plays a role in production, natural killer (NK) cell cytotoxicity, and
the development of some models of glomerulonephritis (GN); T-cell proliferation [1, 2]. It has also been demonstrated
however, the role of IL-18 in the production of IFN- during that IL-18 induces the production of other cytokines,these pathologies has not been studied.
such as interleukin-2 (IL-2) and granulocyte/macrophage-Methods. Rat IL-18 cDNA was isolated and the regulation
of IL-18 gene expression was studied. IFN- and IL-18 expres- colony-stimulating factor (GM-CSF) by T cells, and de-
sion were determined in anti-glomerular basement membrane creases interleukin-10 (IL-10) [2, 3]. IL-18 is involved in
(GBM) antibody (Ab)-induced GN. Recombinant active IL-18 tumor necrosis factor (TNF)- and Fas-ligand-mediated(rIL-18) was used to further identify its effect on IFN- produc-
endotoxin-induced liver injury [4]. In addition, IL-18tion during this GN. Glomerular injury and levels of IFN-
were assayed in Wistar Kyoto (WKY) rats with anti-GBM GN plays a role in antitumor immunity [5]. Increased IL-18
in the presence or absence of rIL-18. expression is associated with autoimmune diseases such
Results. Rat IL-18, similar to the mouse clone, requires pro- as the model of nonobese diabetes in the mouse and,cessing by the IL-1 converting enzyme to become activated.
more recently, at the onset and during the course of activeA rat IL-18 5-untranslated region (UTR) translational inhibi-
tor was identified that strongly inhibited the synthesis of experimental autoimmune encephalomyelitis [6, 7]. IL-18
IL-18. This translational inhibitor with different lengths (180 has also been identified to induce proinflammatory and
and 130 bp) was highly expressed during GN and correlated catabolic responses in articular chondrocytes of patientswith minimal IFN- mRNA expression. Injection of recombi-
with rheumatoid arthritis [8]. These findings indicate thatnant active IL-18 in WKY rats with anti-GBM GN was associ-
ated with an increase of glomerular IFN- levels, proliferating IL-18 plays a role in various immunologic events in in-
cell nuclear antigen (PCNA)-ED1 cells, and PCNA-CD8 flammatory, neoplastic, and autoimmune diseases.
cells, with worsening of glomerular injury. IL-18 is synthesized as a polypeptide precursor (pro-Conclusion. These data suggest that the translational control
IL-18) with no putative hydrophobic signal peptide. Theof IL-18 expression by its 5-UTR limits the production of
IL-18, resulting in restricted expression of mRNA and protein precursor of IL-18 is cleaved after Asp35-X. The interleu-
IFN- in this model of GN. Furthermore, it was suggested kin-1 (IL-1) converting enzyme (ICE) cleaves pro-
that possible IL-18/IFN- induction of local proliferation of IL-18 at the authentic processing site, activating IL-18macrophages and CD8 cells might be an important mechanism
and facilitating its export, as has been demonstrated forfor amplifying CD8-mediated macrophage-dependent GN.
human and mouse pro-IL-18 [6, 7, 9, 10]. The amino
acid sequence of IL-18 includes the IL-1 signature–like1 Dr. Xia’s current address is Torrey Pines Biolabs, 9073 Knight Rd.,
Houston, TX 77054. sequence and presents l5% homology at the amino acid
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T-helper cell immune responses [12]. IFN-, TNF, and as a control (day 0) [18]. At days 3, 5, 7, and 9, three
rats were euthanized at each time point.cytokine products of activated Mφ, such as IL-1, are impli-
cated in the pathogenesis of immune complex–mediated
Riboprobe generation, RNA extraction, and RNaseglomerular injury [13, 14]. Furthermore, IFN- is essen-
protection assaytial for the development of glomerulonephritis (GN) in
(NZBXNZW) F1 and MRL-Faslpr lupus mice. Studies A fragment produced by Xho 1 and Xba 1 (containing
the coding region) of IL-18 cDNA was used for prepara-in MRL-Faslpr mice have suggested that IFN- receptor
signaling is essential not only for the initiation but also tion of the riboprobe. L-32 (92 bp) was generated by PCR
using a cDNA template and was used as a housekeepingfor the acceleration and apoptotic destruction of the
autoimmune kidney [15]. gene. Expression of IFN-mRNA was investigated using
a cytokine probe set (Pharmingen, San Diego, CA, USA).The severe anti-glomerular basement membrane
(GBM) antibody (Ab)-induced crescentic GN of WKY Glomeruli were isolated by sequential sieving through
#60 and #100 wire mesh screens (Small Parts, Inc., Miami,rats is a CD8-dependent and Mφ-related GN [16]. It is
characterized by glomerular infiltration of many cell FL, USA) as previously described [19, 20]. The glomeruli
collected on the #200 mesh screen contained10% tubu-types that are able to produce INF-, including CD4,
CD8, and NK cells. These cells also have been demon- lar contamination. After washing, the glomeruli were
homogenized in 4-M guanidine isothiocyanate with a soni-strated to express IL-18 receptor (IL-18R). Accordingly,
we investigated the involvement of IL-18 in the expres- cator (Heat Systems-Ultrasonics, Plainview, NY, USA).
The RNA was prepared by a single-step method [21].sion of IFN- in this model of crescentic GN. We found
a rat IL-18 5-untranslated region (UTR) translational The RNase protection assay (RPA) was described pre-
viously [20, 22]. Phosphoimage quantitation was per-inhibitor that was responsible for restricted production
of IL-18. This 5-UTR translational inhibitor was ex- formed using the PhosphorImager SI scanning instru-
ment and ImageQuaNT software (Molecular Dynamics,pressed in anti-GBM GN and correlated with a low IFN-
mRNA and protein expression in this model of GN. The Sunnyvale, CA, USA).
treatment with recombinant, active IL-18 of WKY with
Assessment of 5-UTR IL-18 mRNA expressionanti-GBM GN induced an increase of glomerular IFN-
levels and worsening of the GN by increasing CD8 cells Glomerular 5-UTR IL-18 mRNA expression during
anti-GBM GN was determined as described using theand Mφ. These data suggest that tight control of rat
IL-18 expression restricts the production of IFN- in Eco R1 and Hind III 5-UTR fragment of IL-18.
anti-GBM GN in WKY rats, and that IL-18 and IFN-
Construction of a reporter gene for luciferasemight induce local proliferation of inflammatory cells to
(Luc) assayamplify renal injury after the treatment with recombi-
nant active IL-18 (rIL-18) of CD8-mediated Mφ-depen- A Luc 5UT reporter construct was made to study the
role of the IL-18 5-UTR. Luc 5-UT, which contains l86dent GN.
bp of the 5-UTR of rat IL-18, was constructed as follows:
Plasmid pBluscript rat IL-18, which contains the full-
METHODS
length rat IL-18, was digested with Eco RI and Hind III.
Construction of cDNA library, screening, and The Luc-coding region was obtained from the plasmid
DNA sequencing pGL3 promoter by cutting with Hind III and Xba I, and
was subcloned into Hind III and Xba I sites of pBluscript.Primers for rat IL-18 cDNA were generated from mu-
rine cDNA coding for IL-18 (D49949). Polymerase chain pCDNA vector was digested with Eco RI and Not I;
Luc cDNA was digested with Hind III and Not I. Thereaction (PCR)-cloned rat IL-18 cDNA was used to
screen a lipopolysaccharide (LPS)-stimulated rat perito- Eco RI and Hind III 5-UT fragments were then ligated
together to generate pLUC5UT. The Luc-coding regionneal macrophage cDNA library [17]. To investigate the
effect of ICE on the processing of rat IL-18, rat ICE was alone was subcloned into Hind III and Xba I sites of
pCDNA3 to be used as a control. Electroporated withalso cloned from this cDNA library using rat ICE probe
prepared from a portion of a high conserved sequence 10 g of plasmid at 1500 V, 1000 F, and then plated in
3.5 cm plates were 3 105 cells. The cells were harvestedof murine ICE cDNA (U04269).
48 hours later and extracts were prepared for Luc assay
Anti-GBM Ab-induced glomerulonephritis as previously described [23].
Twelve inbred male WKY rats (Charles River Labora-
Transfection of rat IL-18 cDNA with or withouttories, Wilmington, MA, USA) weighing 200 to 220 g
5-UTR in the presence or absence of ICEreceived one intravenous injection of anti-GBM Ab at
a dose of 25 L/100 body weight; three additional rats COS-7 cells (3 105) were transfected by electropora-
tion with pCDM8IL-18 alone (with or without 5-UTR)were given normal rabbit serum (NRS) and were used
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or in combination with an expression plasmid encoding 5 m paraffin sections of NBF-fixed tissue were stained
ICE. After 48 hours of incubation, the supernatants were with periodic acid-Schiff (PAS) reagent. The number of
collected and analyzed for the presence of IL-18 protein crescentic glomeruli per 100 glomeruli of each rat was
by Western blot using IL-18 antiserum. The supernatants calculated and expressed as a percentage. Immunohisto-
also were used to assay the biologic activity of IL-18. chemistry double staining of CD8 and proliferating cell
Total RNA was extracted for RNase protection assay nuclear antigen (PCNA) or ED1 and PCNA were car-
from the cell pellets by the single-step method [21]. ried out as previously described [16]. Proteinuria was
assayed by the sulfosalicylic method.
Expression of rat IL-18 in Escherichia coli and
refolding of rIL-18
RESULTSDNA encoding an active form of rat IL-18 (amino
acid 37 to 194) was PCR-amplified and expressed in a Cloning of rat IL-18 and rat ICE
His-tagged form following a previously described proce- Rat ICE cDNA corresponded to the published se-
dure [24, 25]. IL-18 was refolded on the column using a
quence in the GenBank (accession no. U14647). Therefolding buffer containing a urea gradient of 4 mol/L
conceptualized amino acid sequence derived from theto 0.5 mol/L, which was added at a rate of 0.5 mL/min.
rat IL-18 cDNA clone predicts a protein with a molecularAfter refolding, the protein was eluted with 80 mmol/L
mass of 24 kD and an open reading frame that encodesimidazol/0.5 mol/L urea. A polyclonal antiserum was
for l94 amino acids as a precursor protein (GenBankraised by immunizing a rabbit with rIL-18. After two
accession no. AY077842). The sequence was identical toboosters, the serum was obtained and used for Western
rat IL-18 published by Culhane et al [27]. The rat aminoblot.
acid sequence was 90.2% homologous with mouse IL-18
Western blot and 64.9% with human IL-18, respectively. Analogous
to these mouse and human proteins, rat IL-18 containsThe samples were electrophoresed on a 4–12% Nu-
the IL-1 signature sequence. At the putative processingPage bis-tris gel (NOVEX, San Diego, CA, USA) and
site, a conserved Asp-X sequence in the rat, as well aswere then transblotted onto a nitrocellulose filter (Schlei-
other species, suggests the importance of this amino acidcher & Schuell, Inc., Keene, NH, USA). The blot was
in the maturation of IL-18 (Fig. 1).incubated in the rabbit-anti IL-18 Ab solution (1:2000
A difference among rat IL-18 and mouse and humandilution) and then treated with goat-anti-rabbit immuno-
globulin G (IgG) conjugated with alkaline phosphatase IL-18 was found in the 5-UT region; human IL-18 con-
(1:1500 dilution; Boehringer Mannheim, Indianapolis, tains 177 bp (GenBank accession no. D49950) and mouse
IN, USA) [26]. IL-18 contains 164 bp (GenBank accession no. D49949)
at the 5-UT region, respectively. In contrast, the rat
Biologic activity of IL-18 IL-18 contains a longer 5-UT region of 228 bp. At the
IL-12 (10 pg/mL) primed plastic nonadherent spleen 5-UT region the homology between the 164 bp sequence
cells (4 l06/mL, 0.1 mL/well) were incubated with either of mouse IL-18 and the 164 bp sequence adjacent to the
recombinant His-tagged rat IL-18 or supernatants de- ATG codon of rat IL-18 was 80.4%, and 33.8% for hu-
rived from transfected COS-7 cells. Following incuba- man IL-18 in 177 bp (Fig. 2)
tion, supernatants were collected and IFN- titers were
determined by enzyme-linked immunoassay (ELISA). IFN- and IL-18 mRNA expression during crescentic GN
A small increase in expression of IFN- mRNA wasDetermination of rIL-18 effect during anti-GBM GN
found in anti-GBM GN in WKY rats, in contrast with
Six additional rats with anti-GBM GN were used to
high expression of other cytokines such as IL-1, IL-1,study the effect of active IL-18; three rats received phos-
IL-4, IL-6, and TNF- (Fig. 3A). Ribonuclease protec-phate-buffered saline (PBS), and three were given 50 g
tion assay (RPA) using a probe containing the codingof active IL-18 intravenous for 5 days and sacrificed on
region of IL-18, revealed a low basal level of IL-18day 6. As a control, three normal WKY rats received
mRNA that substantially increased during anti-GBMactive IL-18 as above. IFN- expression in glomeruli
GN. Maximum expression occurred at days 3 and 5, andwas determined by ELISA. Levels of IFN- were also
then decreased at days 7 and 9 (Fig. 3B). ELISA analysismeasured in liver to determine whether the effects of
of INF- protein confirmed little increase of protein lev-administration of recombinant IL-18 were restricted to
els of this cytokine in nephritic glomeruli (control vs.nephritic glomeruli. For histopathology study, kidney
anti-GBM GN, 100 	 20 vs. 180.66 	 35.2 pg/mL, P 
tissue samples were fixed in 10% neutralized buffered
0.05) and correlated with the low expression levels offormalin (NBF), or methol-Carnoy fixative solution, and
embedded in paraffin. For light microscopy examination, IFN- mRNA during this model of GN.
Garcia et al: Regulation of IFN- by IL-18 in crescentic GN 163
Fig. 1. Amino acid sequence of rat interleu-
kin-18 (IL-18). Homology of rat IL-18 with
mouse and human IL-18 is shown. The IL-1
signature sequence is underlined. The se-
quence of the putative processing site is indi-
cated by italics (for rat and human Asp36-X
and for mouse Asp35-X).
Fig. 2. Base pair sequence of rat, mouse, and
human interleukin-18 (IL-18) 5-UTR. Arrows
represent the fragment used as a riboprobe
during RNase protection assay.
Expression of 5-UTR IL-18 mRNA in anti-GBM GN 5-UTR in COS-7 cells was determined. For this purpose,
a specific anti-IL-18 Ab was generated for Western blot.When a probe with the 5-UTR of rat IL-18 was tested,
This Ab recognized IL-18 expressed in COS-7, but didwe found that most of the mRNA for IL-18 was the
not recognize any protein in supernatants from antisense5-UT containing transcript (Fig. 3C). Two different tran-
transfectants (Fig. 4A). We found that only coexpressionscripts of the 5-UTR were expressed during anti-GBM
of pro-IL-18 and ICE without the 5-UTR resulted inGN, one transcript of 180 bp that was not constitutively
the cleavage of the 24 kD pro-IL-18 into the expectedexpressed, and a second transcript that was 50 bp shorter.
18 kD mature IL-18 fragment. In the presence of 5-UTR,Peak expression occurred at days 3 and 5 for both tran-
neither l8 kD nor 24kD pro-IL-18 could be detected byscripts (Fig. 3C).
Western blot (Fig. 4A). The RPA showed that IL-18
The role of 5-UTR in the translational control of IL-18 mRNA was transcribed with no difference in COS-7 cells
transfected with IL-18, whether the 5-UTR region wasTo address the role of the 5-UTR of rat IL-18 mRNA
present or not (Fig. 4B).in modulating the translation of this message and to ex-
These data suggested the presence of an IL-18 5-plain the dissociation between high expression of IL-18
UTR translational inhibitor. To demonstrate that thisgene and low expression of IFN- mRNA during anti-
translational effect was specific to the IL-18 leader se-GBM GN, several experiments were performed. In the
first experiment, the expression of IL-18 with or without quence, we made a chimeric gene in which IL-18 5-
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Fig. 3. Analysis of interferon gamma (IFN-) and interleukin-18 (IL-18) expression in the glomeruli of crescentic glomerulonephritis (CGN) in
Wistar Kyoto (WKY) rats. (A ) RNase protection assay of cytokine set. Eleven cytokines were tested, and L-32 and glyceraldehydes-3-phosphate
dehydrogenase (GAPDH) were used as housekeeping genes. Only cytokines expressed are shown. (B ) RNase protection analysis of IL-18 coding
region. IL-18 mRNA expression is expressed as the ratio of IL-18 to L32 X 10. (C ) RNase protection assay of IL-18 5-UTR region. The figure
shows two different transcripts, one of 180 bp and the second 50 bp shorter. Probes contain polylinker regions and are longer than the protected
bands. Each lane represents one rat sample.
Fig. 4. (A ) Protein expression of interleukin-
18 (IL-18) in transfected COS-7 cells. Cleaved
pro-IL-18 is demonstrated in the supernatant
from COS-7 cotransfected with IL-18 and ICE
(IL-18 ICE) without the 5-UTR. The upper
band is the remainder of undigested pro-IL-18.
IL-18 protein expression was found in the su-
pernatant of IL-18 without 5-UTR transfec-
tant in two different samples [5-UTR(–) a
and b], whereas no protein expression was
found in supernatant from COS-7 cells trans-
fected with IL-18 in the presence of 5-UTR
[5-UTR()]. Recombinant rat IL-18 ex-
pressed in E. coli and refolded, showing a
larger size than the expected 18 kD due to the
extra AA fused with IL-18 during expression.
(B ) RNase protection assay of COS-7 trans-
fected with IL-18 in the presence or absence
of IL-18 5-UTR.
UTR was fused with the luciferase reporter gene; the grated light units (ILU) against l,093,545 ILU for the
plasmid without the IL-18 5-UTR]. Furthermore, whenresults of duplicate assays demonstrated that the con-
struct containing the rat IL-18 5-UTR inhibited Luc the bioactivity of IL-18 was determined, supernatants
from COS-7 coexpressing ICE and pro-IL-18 without 5-gene expression by 35.4% in a chimera [706,381 inte-
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were localized in areas of severe tissue damage. These
data demonstrated that when the suppression of transla-
tion of IL-18 is bypassing using rIL-18, an increase of
IFN- is induced in this model of GN, with worsening
renal damage.
In contrast to the increased levels of INF- in the
nephritic glomeruli after the treatment with rIL-18, lev-
els of liver IFN-were not detectable in rats that received
rIL-18 or PBS.
In healthy rats, treatment with IL-18 caused no dam-
age in the kidney; consequently, urine protein levels were
not different from those observed in normal WKY that
did not receive IL-18 (3.3 vs. 2.7 mg/24 hours).
DISCUSSION
IFN-, a cytokine secreted by activated T cells and
Fig. 5. Biologic activity of interleukin-18 (IL-18) of supernatants de-
NK cells, has immunomodulatory effects on several cellrived from transfected COS-7 cells with IL-18 (with or without 5-UTR)
and interleukin-1 converting enzyme (ICE). Recombinant rat IL-18 types [28]. IFN- is a cytokine that activates Mφ; in addi-
at different concentrations and supernatant from the macrophage cell tion, IFN- contributes to the regulation of the T-helper
line Raw 264.7 (at dilutions of 1:40 and 1:400) were used as positive
cell immune response [12, 28]. NK cells exhibit enhancedcontrol. Minimal production of interferon gamma (IFN-) was found
in the supernatants from COS-7 cells coexpressing ICE and pro-IL-18 cytolitic activity in response to IFN- in vivo and in
in the presence of 5-UTR [ICE/5UTR ()] in contrast with the high vitro [12, 28]. IFN- cytokine plays a role in several
bioactivity of transfectant without 5-UTR [ICE/5UTR ()], using the
autoimmune diseases, including GN. It has been demon-same dilutions (1:4 and 1:40). A little background was found in the
transfectant of ICE alone. strated that levels of IFN- in the sera of patients with
autoimmune disorders are significantly elevated [29]. In-
hibition of IFN- or treatment with soluble IFN-R at-
tenuates F1 lupus–like nephritis [29–31]. In addition, inUTR could stimulate IL-12–primed nonadherent splenic
a model of anti-GBM GN in Sprague-Dawley rats andcells to produce IFN-; conversely, cells cotransfected
in C57BL/6 mice, significantly increased levels of IFN-with ICE and pro-IL-18 containing 5-UTR only pro-
were detected [32]. In contrast with other models of GN,duced minimal levels of IFN- (Fig. 5).
low levels of IFN- mRNA and protein expression wereDetermination of IL-18 protein expression in nephritic
found during anti-GBM GN in WKY rats, despite theglomeruli by Western blot resulted in the lack of detec-
presence of IL-18 gene expression, a potent inducer oftion of IL-18 protein, supporting the inefficient transla-
IFN- production. We found the presence of a long 5-tion of IL-18 mRNA by its 5-UTR. These results suggest
UTR in rat IL-18; when IL-18 was transfected in thethat the 5-UTR of rat IL-18 is a potent inhibitor of
presence of its 5 flanking sequence, IL-18 protein couldtranslation.
not be detected. Furthermore, the construction of an
Effect of recombinant IL-18 in rats with anti-GBM GN expression vector in which IL-18 5-UTR was placed
flanking the luciferase coding sequence, the luciferaseTo investigate the potential role of IL-18 during GN,
gene expression was inhibited, suggesting the presencea biologically active rat IL-18 was injected for 5 days
of an IL-18 5-UTR translational inhibitor. This transla-into WKY rats with anti-GBM GN. Rats treated with
tional inhibitor was highly expressed in anti-GBM GNrIL-18 showed a 2.4-fold higher IFN- production in
in WKY rats and correlated with a low expression ofglomeruli (443.33 	 39.5 vs. 180.66 	 35.2 pg/mL, P 
IFN- mRNA and lack of detection of IL-18 protein0.05). This led to a 3.1-fold increase of proteinuria (37.2	
levels in nephritic glomeruli. These data suggest that0.72 vs. 12.3 	 0.58 mg/24 hours, P  0.001). The fre-
IFN- and IL-18 play a minimal role in this model ofquency of crescentic glomeruli was dramatically in-
GN. Conversely, the treatment with rIL-18 of WKY withcreased in rats treated with rIL-18 (85% vs. 55%, P 
anti-GBM GN induced an increase of glomerular IFN-0.001) (Fig. 6).
associated with a more severe glomerular damage, al-Double immunohistochemistry staining of ED1Mφ
though no effect was observed in control WKY rats.or CD8 cells and the PCNA showed a large number of
IL-18 administration in mice without GN did not alterproliferating Mφ (ED1PCNA) (29.8 	 5.6 vs. 17.8 	
glomerular histology has also been previously reported3.7 per glomerular cross-section, P  0.01) and CD8
[33]. The lack of effect of IL-18 in healthy WKY rats iscells (CD8PCNA) (7.6	 1.2 vs. 5.8	 1.8 per glomeru-
lar cross-section, P  0.05) (Fig. 7). Proliferating cells consistent with previous findings, in which in mice not
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Fig. 6. (a, c, e ) Photomicrograph of glomeruli from Wistar Kyoto (WKY) rats with crescentic glomerulonephritis (CGN) that were treated with
phosphate-buffered saline (PBS) or (b, d, f ) rIL-18. (a to d) Kidney section immunohistochemistry stained for ED1/Mo/Mφ (magnification of a
and b, 200; magnification of c and d, 400). (e) Periodic acid-Schiff (PAS) staining of kidney section of PBS- or (f) rIL-18-treated rats.
primed, the administration of IL-18 does not increase by IL-18 in order to induce IFN- production, leading
to tissue injury. It is also suggested that IL-18 is a cofactorplasma levels of IFN- or induce damage in the liver or
other organs. However, induction of obstructive jaundice in the induction of IFN- production, since treatment
with IL-18 and IL-12, but not with IL-18 alone, stimulatesprior to the treatment with IL-18 induces large amounts
of IFN- and liver injury, and the combined treatment the production of INF-. However, whether longer time
treatment with IL-18 alone without priming phase couldof IL-18 plus IL-12 in mice not primed induces elevated
levels of IFN- and liver damage [4, 34, 35]. These data cause tissue injury remains to be determined. In spite of
the deleterious effects of the treatment with IL-18 in thesuggest that a priming phase that activates the immune
system should precede a late excitation phase elicited kidney of anti-GBM rats, IFN- levels in the liver were
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Fig. 7. Photomicrograph of glomeruli from Wistar Kyoto (WKY) rats with crescentic glomerulonephritis (CGN) treated with rIL-18. (a and b )
Kidney sections were immunohistochemically stained for CD8 and proliferating cell nuclear antigen (PCNA) and (c and d ) macrophages (Mφ)
and PCNA. (b) and (d) Magnification of marked areas from (a) and (c), 400. Blue arrows indicate PCNA staining; brown arrows indicate staining
of inflammatory cells; and black arrows denote costaining of PCNA and inflammatory cells.
not affected in these rats. This preferential effect of IL-18 tential mechanisms besides the presence of stable steam
loops for repressing translation should be considered.in nephritic glomeruli supports the theory that a preced-
ing inflammatory insult is necessary for IL-18 to augment The formation of mRNA-protein complexes in the 5-
UTR has been described to control translation initiationIFN- production with a further tissue injury [4, 34, 35].
The presence of the 5-UTR and/or 3-UTR regions by steric blockage of a sensitive step in the initiation
pathway. As an example, HuR, a related member of theaffects translational efficiency and in turn can be a mech-
anism of gene regulation [36]. Two factors that have human Hu/Elav protein family (a family of RNA-binding
factors) that is ubiquitously expressed, was previouslybeen demonstrated to influence the translatability of
mRNA are present in rat IL-18: extensive structure in identified as a protein binding to a U-rich element in
the p27 5-UTR to inhibit its translation [40, 41]. It will bethe 5-UTR and the presence of a minicistron, a short
open reading frame (ORF) upstream of the actual trans- interesting to investigate whether IL-18 mRNA contains
HuR binding sites in its 5-UTR.lation start site [36]. It is probable that the long 5-UTR
forms a secondary structure, such as a hairpin, which in The presence of two different lengths of IL-18 5-
UTR in this model of GN suggests that they arise fromturn inhibits translation in a position-dependent mecha-
nism. There are other examples of a 5-untranslated leader alternative splicing. It is probable that the shorter tran-
script may correspond to a nonfunctional, silent tran-sequence acting as a potent translational inhibitor. In bo-
vine aldehyde dehydrogenase, platelet-derived growth script by retaining at least part of one intron.
This study indicates that rat IL-18 is regulated at multi-factor-2, and ornitine decarboxylase, the 5-UTR sup-
presses translation of its own coding sequence. In all ple steps, including transcriptional, post-transcriptional,
translational, and post-translational levels. Recently itthree cases, very stable hairpin structures have been pre-
dicted by computer analysis [37–39]. However, other po- has been demonstrated that pro-IL-18 and mature IL-18
Garcia et al: Regulation of IFN- by IL-18 in crescentic GN168
are degraded to biologically inactive forms by caspase-3 CONCLUSION
in monocytic THP.1 cells. Because of the detrimental These results indicate that tight translational control of
effects in the case of overexpression or lack of expression rat IL-18 expression restricts the production of IFN- in
of IFN- and IL-18, it would be advantageous to have anti-GBM GN in WKY rats, and that IL-18 and IFN-
IL-18 under strict regulatory control. Similar tight con- might induce local proliferation and infiltration of inflam-
trol is observed with another cytokine, TNF-, in which matory cells in order to amplify renal injury after the treat-
diverse cis-acting elements and transacting factors are ment with rIL-18 of CD8-mediated Mφ-dependent GN.
involved in TNF- gene expression. A cell type–specific
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